Global Diabetic Care Devices Market

Report Scope

This report provides an analysis of the market for diabetes monitoring devices, along with a competitive landscape and profiles of key companies that include their revenues, product portfolios and recent activities. It analyzes trends and market dynamics, including drivers, limitations, challenges, and opportunities, and discusses historical, current and potential market size. The report will enable readers to make informed decisions about the production and licensing of goods and services, as well as market developments and trends. The study segments the market by product type, including self-monitoring blood glucose (SMBG) devices such as blood glucose meter devices, blood glucose test strips, lancets and lancet devices; and continuous glucose monitoring (CGM) device products, including transmitters and receivers. A regional market analysis, including country-level analysis, is provided for all segments. The report covers only diabetes monitoring devices; diabetes therapeutic devices, which include insulin delivery systems and any other equipment used in hospitals are outside the scope of the report.

Self-monitoring blood glucose (SMBG) devices:

Blood glucose meter devices.

Blood glucose test strips.

Lancets and lancet devices.

Continuous glucose monitoring (CGM) systems:

Sensors and transmitters.

Receivers.

End users:

Hospitals.

Home care settings.

Diagnostic centers.

Report Includes:

30 data tables and 47 additional tables

An analysis of the global market for diabetes care devices, including self-glucose monitoring devices and continuous glucose monitoring systems

Analyses of the global market trends, with market revenue data (sales figures) for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029

Estimates of the market size and revenue prospects, along with a corresponding market share analysis by product type and sub-type, end user and region

Discussion of the market potential and opportunities in the diabetes care industry, along with an analysis of the competitive environment, regulatory scenario and technological advances

Facts and figures pertaining to R&D activity, industry-specific challenges, and the impact of macroeconomic factors

Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies

Patent analysis featuring key granted and published patents

Emerging new developments and clinical trials in the diabetes care market

Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook

Profiles of leading companies, including Abbott, Medtronic, Dexcom Inc., F. Hoffmann-La Roche Ltd., and LifeScan IP Holdings LLC.

Companies Mentiioned

ABBOTT
ACON LABORATORIES INC.
AGAMATRIX
ARKRAY INC.
B. BRAUN SE
DEXCOM INC.
F. HOFFMANN-LA ROCHE LTD.
I-SENS INC.
LIFESCAN IP HOLDINGS LLC.
MEDTRONIC
PHC HOLDINGS CORP.
SENSEONICS
SINOCARE
TERUMO CORP.
YPSOMED